72 Investment Holdings, LLC - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 56 filers reported holding ENTRADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.1%.

Quarter-by-quarter ownership
72 Investment Holdings, LLC ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,042,563
+4.4%
509,0230.0%53.88%
-10.3%
Q2 2023$7,706,608
+4.4%
509,0230.0%60.04%
+1618.0%
Q1 2023$7,380,833
+7.2%
509,0230.0%3.50%
+10.5%
Q4 2022$6,881,991
-14.2%
509,0230.0%3.16%
-50.2%
Q3 2022$8,022,000
+29.4%
509,0230.0%6.36%
-33.7%
Q2 2022$6,200,000
+29.7%
509,0230.0%9.58%
+83.2%
Q1 2022$4,780,000
-45.1%
509,023
-0.0%
5.23%
-32.4%
Q4 2021$8,714,000509,0247.73%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 509,023$7,706,60860.04%
MPM ASSET MANAGEMENT LLC 4,425,784$67,006,37032.86%
5AM Venture Management, LLC 4,408,379$66,742,85816.63%
StepStone Group LP 761,277$11,525,7342.13%
TCG Crossover Management, LLC 584,955$8,856,2191.45%
Redmile Group, LLC 1,311,572$19,857,2000.76%
Nan Fung Group Holdings Ltd 49,082$743,1010.48%
Baker Brothers Advisors 4,865,819$73,668,5000.43%
Corton Capital Inc. 18,067$273,5340.13%
MOORE CAPITAL MANAGEMENT, LP 105,000$1,589,7000.03%
View complete list of ENTRADA THERAPEUTICS INC shareholders